CN102166375B - Reconstruction method of tissue engineering human corneal epithelium - Google Patents
Reconstruction method of tissue engineering human corneal epithelium Download PDFInfo
- Publication number
- CN102166375B CN102166375B CN 201110039099 CN201110039099A CN102166375B CN 102166375 B CN102166375 B CN 102166375B CN 201110039099 CN201110039099 CN 201110039099 CN 201110039099 A CN201110039099 A CN 201110039099A CN 102166375 B CN102166375 B CN 102166375B
- Authority
- CN
- China
- Prior art keywords
- culture
- human corneal
- corneal epithelium
- tissue
- epithelial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003560 epithelium corneal Anatomy 0.000 title claims abstract description 64
- 238000000034 method Methods 0.000 title claims abstract description 25
- 210000001519 tissue Anatomy 0.000 title claims abstract description 25
- 210000002919 epithelial cell Anatomy 0.000 claims abstract description 53
- 210000001691 amnion Anatomy 0.000 claims abstract description 41
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims abstract description 32
- 244000309466 calf Species 0.000 claims abstract description 20
- 238000000338 in vitro Methods 0.000 claims abstract description 20
- 102000004142 Trypsin Human genes 0.000 claims abstract description 17
- 108090000631 Trypsin Proteins 0.000 claims abstract description 17
- 239000012588 trypsin Substances 0.000 claims abstract description 17
- 210000005081 epithelial layer Anatomy 0.000 claims abstract description 14
- 210000002966 serum Anatomy 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 51
- 239000000243 solution Substances 0.000 claims description 51
- 239000006285 cell suspension Substances 0.000 claims description 19
- 210000004087 cornea Anatomy 0.000 claims description 19
- 230000029087 digestion Effects 0.000 claims description 17
- 239000012531 culture fluid Substances 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000010410 layer Substances 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 239000012981 Hank's balanced salt solution Substances 0.000 claims description 6
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims description 5
- 229930182566 Gentamicin Natural products 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 5
- 210000000981 epithelium Anatomy 0.000 claims description 5
- 239000002356 single layer Substances 0.000 claims description 5
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 4
- 239000000645 desinfectant Substances 0.000 claims description 4
- 229940116978 human epidermal growth factor Drugs 0.000 claims description 4
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 claims description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 claims 3
- 238000001556 precipitation Methods 0.000 claims 2
- 210000003425 amniotic epithelial cell Anatomy 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 102000004266 Collagen Type IV Human genes 0.000 abstract description 7
- 108010042086 Collagen Type IV Proteins 0.000 abstract description 7
- 239000002609 medium Substances 0.000 abstract description 6
- 238000002054 transplantation Methods 0.000 abstract description 6
- 230000003698 anagen phase Effects 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 238000010923 batch production Methods 0.000 abstract 1
- 238000012136 culture method Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 description 37
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 26
- 229910002092 carbon dioxide Inorganic materials 0.000 description 13
- 239000011521 glass Substances 0.000 description 8
- 239000012982 microporous membrane Substances 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 201000004569 Blindness Diseases 0.000 description 5
- 210000004045 bowman membrane Anatomy 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229960002518 gentamicin Drugs 0.000 description 4
- 208000028006 Corneal injury Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 231100001221 nontumorigenic Toxicity 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- -1 carboxymethyl chitosan oligosaccharide Chemical compound 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 208000021921 corneal disease Diseases 0.000 description 1
- 210000003683 corneal stroma Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002514 epidermal stem cell Anatomy 0.000 description 1
- 230000008378 epithelial damage Effects 0.000 description 1
- 230000009841 epithelial lesion Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 210000000110 microvilli Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及一种组织工程人角膜上皮的重建方法,是利用含20%小牛血清的DMEM/F12培养液将人角膜上皮细胞体外培养至对数生长期,采用胰蛋白酶和胰蛋白酶-EDTA消化法获得完全去除上皮层的消化羊膜载体支架,平铺在插入式培养皿中牢固干贴后,将悬浮于含有IV型胶原蛋白和10%小牛血清的DMEM/F12培养液的对数生长期人角膜上皮细胞,接种至平铺有去上皮层消化羊膜载体支架的插入式培养皿中采用气-液界面培养法进行组织工程人角膜上皮的体外重建。本发明工艺科学合理,所重建的组织工程人角膜上皮可用于批量生产,满足广大角膜上皮病盲患者临床角膜移植治疗对组织工程人角膜上皮的大量需求,且组织工程人角膜上皮体外重建和临床治疗的成本低。The present invention relates to a reconstruction method of tissue engineered human corneal epithelium. Human corneal epithelial cells are cultured in vitro to the logarithmic growth phase with DMEM/F12 culture solution containing 20% calf serum, and digested with trypsin and trypsin-EDTA. The digested amniotic membrane carrier scaffold that completely removed the epithelial layer was obtained by the method, and after it was flatly spread in the insert culture dish and dried firmly, it was suspended in the logarithmic growth phase of DMEM/F12 medium containing type IV collagen and 10% calf serum. Human corneal epithelial cells were inoculated into an insert culture dish covered with de-epithelialized digested amnion carrier scaffolds, and the tissue-engineered human corneal epithelium was reconstructed in vitro by air-liquid interface culture method. The process of the present invention is scientific and reasonable, and the reconstructed tissue-engineered human corneal epithelium can be used in batch production to meet the large demand for tissue-engineered human corneal epithelium in the clinical corneal transplantation treatment of blind patients with corneal epithelial diseases, and the tissue-engineered human corneal epithelium can be reconstructed in vitro and clinically. The cost of treatment is low.
Description
技术领域 technical field
本发明属于角膜上皮构建技术领域,具体涉及一种组织工程人角膜上皮的重建方法,即利用人角膜上皮细胞和脱上皮层消化羊膜来重建组织工程人角膜上皮的方法。The invention belongs to the technical field of corneal epithelium construction, and in particular relates to a method for reconstructing tissue-engineered human corneal epithelium, that is, a method for reconstructing tissue-engineered human corneal epithelium by using human corneal epithelial cells and de-epithelialized amniotic membranes.
背景技术 Background technique
人角膜上皮层由多层上皮细胞组成,是角膜的第一道屏障,可以防止角膜水分的散失和外界病原体的入侵,并阻止泪液中液体和电解质进入基质层,使角膜处于透明状态;此外,角膜上皮细胞表面的微绒毛和泪膜相互作用,为透明角膜的前屈光面提供光学界面(谢立信,2000)。由于角膜上皮层直接与外界接触,故易受到损伤和感染而引起角膜上皮损伤或病变,导致视力下降,严重者会引起角膜上皮盲(樊廷俊等,2010)。角膜病是仅次于白内障的第二大致盲眼病,其中多数是由于角膜上皮结构和功能异常所引起的(Whitcher等,2001)。角膜上皮移植是目前角膜上皮病盲治愈的唯一途径,但由于捐献的供体角膜数量严重不足,致使绝大多数角膜上皮盲病患者无法通过角膜上皮移植而重见光明。近年来,角膜组织工程的兴起使体外重建出形态结构正常的组织工程角膜上皮成为可能,是目前解决供体角膜材料不足的一种新的可行途径,为角膜上皮病盲患者的临床治疗带来了新的希望,但如何利用角膜上皮细胞和适宜的载体支架在体外重建出组织工程人角膜上皮已经成为研究热点。The human corneal epithelium is composed of multiple layers of epithelial cells, which is the first barrier of the cornea, which can prevent the loss of corneal water and the invasion of external pathogens, and prevent the liquid and electrolytes in tears from entering the stroma, so that the cornea is in a transparent state; in addition, The microvilli on the surface of the corneal epithelium interact with the tear film to provide an optical interface for the anterior refractive surface of the transparent cornea (Xie Lixin, 2000). Because the corneal epithelium is in direct contact with the outside world, it is vulnerable to damage and infection, which can cause corneal epithelial damage or lesions, leading to vision loss, and severe corneal epithelial blindness (Fan Tingjun et al., 2010). Corneal disease is the second leading cause of blindness next to cataract, most of which are caused by abnormal structure and function of corneal epithelium (Whitcher et al., 2001). Corneal epithelial transplantation is currently the only way to cure corneal epithelial blindness. However, due to the severe shortage of donor corneas, most patients with corneal epithelial blindness cannot regain their sight through corneal epithelial transplantation. In recent years, the rise of corneal tissue engineering has made it possible to reconstruct tissue-engineered corneal epithelium with normal morphological structure in vitro. However, how to use corneal epithelial cells and suitable carrier scaffolds to reconstruct tissue-engineered human corneal epithelium in vitro has become a research hotspot.
利用组织工程技术对人角膜上皮的体外重建研究开始于1993年,许多学者先后利用诱导分化的角膜缘干细胞、表皮干细胞、骨髓间充质干细胞、口腔黏膜上皮细胞和羊膜上皮细胞等作为种子细胞,以复合胶原、羊膜、脱细胞角膜基质、壳聚糖、纤维蛋白和聚异丙基丙烯酰胺凝胶等为载体支架开展了组织工程人角膜上皮的体外重建研究(Minami等,1993;Koizumi等,2001;Nakamura等,2003;Jin等,2004;Ma等,2006;樊廷俊等,2010),且移植后可使角膜创伤兔或角膜损伤患者恢复一定的视力。这些研究结果为组织工程人角膜上皮的体外重建开辟了道路,但由于所用种子细胞均为诱导分化的细胞,因种子细胞来源有限,或因仍具有原有种类细胞的特点,故无法开展组织工程人角膜上皮的规模化体外重建,或体外重建的组织工程人角膜上皮因结构功能不稳定而无法临床应用,目前仍只限于实验研究。The in vitro reconstruction of human corneal epithelium using tissue engineering technology began in 1993. Many scholars have used induced differentiation of limbal stem cells, epidermal stem cells, bone marrow mesenchymal stem cells, oral mucosal epithelial cells and amniotic membrane epithelial cells as seed cells. Using composite collagen, amniotic membrane, decellularized corneal stroma, chitosan, fibrin, and polyisopropylacrylamide gel as carrier scaffolds, the in vitro reconstruction study of tissue-engineered human corneal epithelium was carried out (Minami et al., 1993; Koizumi et al., 2001; Nakamura et al., 2003; Jin et al., 2004; Ma et al., 2006; Fan Tingjun et al., 2010), and after transplantation, rabbits with corneal trauma or patients with corneal injury can restore certain vision. These research results have opened up the way for the in vitro reconstruction of tissue engineered human corneal epithelium, but because the seed cells used are all induced differentiation cells, the source of seed cells is limited, or because they still have the characteristics of the original type of cells, tissue engineering cannot be carried out Large-scale in vitro reconstruction of human corneal epithelium, or in vitro reconstruction of tissue engineered human corneal epithelium cannot be used clinically due to unstable structure and function, and is still limited to experimental research.
2009年,樊廷俊等成功建立了非转染、无致瘤性的人角膜上皮细胞系,并从中筛选出核型正常且结构功能正常的角膜上皮细胞株,成功解决了人组织工程角膜上皮规模化重建所需大量种子细胞的来源问题。因此,尽早建立一种利用人角膜上皮细胞单克隆细胞株和去上皮层消化羊膜在体外重建组织工程人角膜上皮的方法,已成为各国学者的主攻目标,也是组织工程角膜上皮规模化生产及临床应用造福全世界角膜上皮病盲患者的关键。In 2009, Fan Tingjun and others successfully established a non-transfection, non-tumorigenic human corneal epithelial cell line, and screened out a corneal epithelial cell line with normal karyotype and normal structure and function, successfully solving the problem of large-scale human tissue engineering corneal epithelial cell line. The source of the large number of seeded cells required for reconstitution. Therefore, establishing a method for reconstructing tissue-engineered human corneal epithelium in vitro using human corneal epithelial cell monoclonal cell lines and de-epithelialized amniotic membrane has become the main goal of scholars from all over the world. Application is the key to benefit blind patients with corneal epithelial disease worldwide.
发明内容 Contents of the invention
本发明的目的是提供一种组织工程人角膜上皮的重建方法,利用人角膜上皮细胞单克隆细胞株和去上皮层消化羊膜载体支架来体外重建人角膜上皮,从而满足患者对角膜上皮的移植需求,以弥补现有技术的不足。The purpose of the present invention is to provide a method for reconstructing tissue engineered human corneal epithelium, which utilizes human corneal epithelial cell monoclonal cell lines and de-epithelialized amnion carrier scaffolds to reconstruct human corneal epithelium in vitro, thereby meeting the patient's corneal epithelial transplantation needs , to make up for the deficiencies of the prior art.
本发明的重建方法包括如下步骤:The reconstruction method of the present invention comprises the following steps:
1)人角膜上皮种子细胞悬液的制备:1) Preparation of human corneal epithelial seed cell suspension:
取人角膜上皮细胞系的细胞,用含20%小牛血清的DMEM/F12培养液在37℃扩增培养至对数生长期,经0.25%胰蛋白酶溶液消化和1000~1500转/分钟离心10~15分钟获得人角膜上皮细胞沉淀,再用含有10%小牛血清和0.005%~0.01%IV型胶原蛋白的DMEM/F12培养液将该细胞沉淀悬浮成人角膜上皮细胞悬液,经细胞计数后,调整细胞浓度至8×106~3×107个细胞/毫升;Take the cells of human corneal epithelial cell line, use DMEM/F12 culture medium containing 20% calf serum to amplify and culture at 37°C to the logarithmic growth phase, digest with 0.25% trypsin solution and centrifuge at 1000-1500 rpm for 10 The human corneal epithelial cell pellet was obtained in ~15 minutes, and then the cell pellet was suspended in the human corneal epithelial cell suspension in DMEM/F12 medium containing 10% calf serum and 0.005%-0.01% type IV collagen, and the cells were counted , adjust the cell concentration to 8×10 6 -3×10 7 cells/ml;
其中人角膜上皮细胞系的构建方法是:将角膜取出后用含抗生素的消毒液消毒,再将角膜进行消化处理后,取下带有前弹力层的角膜上皮,剪成小的角膜上皮组织块后,将角膜上皮组织块向下贴于培养孔的底部,使前弹力层向上;然后加入培养液在二氧化碳培养箱中、37℃下进行贴板培养,培养期间换培养液,细胞长成单层后用胰酶消化法进行继代培养,传代至60代以上完成了人角膜上皮细胞系的构建;其中,培养液为含有20%胎牛血清、0.02‰~0.04‰的人表皮细胞生长因子、0.01‰~0.02‰的人碱性成纤维细胞生长因子、0.4‰~1.0‰羧甲基壳寡糖和0.25‰~1‰硫酸软骨素的DMEM/F12培养液。The method for constructing the human corneal epithelial cell line is: take out the cornea and disinfect it with a disinfectant solution containing antibiotics, then digest the cornea, remove the corneal epithelium with the Bowman's membrane, and cut it into small corneal epithelial tissue pieces Finally, paste the corneal epithelial tissue pieces downward on the bottom of the culture hole, so that the Bowman's membrane is upward; then add culture medium and carry out plate culture in a carbon dioxide incubator at 37°C. During the culture period, the culture medium is changed, and the cells grow into single The human corneal epithelial cell line was constructed by passage to more than 60 generations; the culture medium was human epidermal growth factor containing 20% fetal bovine serum and 0.02‰~0.04‰ , 0.01‰~0.02‰ human basic fibroblast growth factor, 0.4‰~1.0‰ carboxymethyl chitosan and 0.25‰~1‰ chondroitin sulfate in DMEM/F12 culture medium.
上述的含抗生素的消毒液为用0.9%生理盐水配制的质量比浓度为20%~70%的庆大霉素溶液。The above antibiotic-containing disinfectant is a gentamicin solution with a mass ratio concentration of 20% to 70% prepared with 0.9% physiological saline.
上述的角膜进行消化处理是用浓度为0.2~0.5%的胰蛋白酶溶液消化,消化时间为1~2min。The above cornea is digested with a trypsin solution with a concentration of 0.2-0.5%, and the digestion time is 1-2 minutes.
2)载体支架的制备2) Preparation of carrier scaffold
利用0.25%胰蛋白酶-0.1%EDTA溶液对冻干羊膜的上皮面进行倒置消化,以得到完全去除上皮层的羊膜,用D-hanks溶液漂洗2次后,用打孔器将去上皮层消化羊膜打成与6孔培养板插入式培养皿孔径相同的去上皮层消化羊膜圆片,使其上皮面朝上平铺于插入式培养皿的底部,放置于5%CO2培养箱中在37℃条件下牢固干贴后制成载体支架备用;Use 0.25% trypsin-0.1% EDTA solution to digest the epithelial surface of the freeze-dried amniotic membrane upside down to obtain the amniotic membrane with the epithelial layer completely removed. After rinsing twice with D-hanks solution, use a puncher to digest the epithelial layer of the amniotic membrane Digested amniotic membrane discs with the same pore size as the 6-well culture plate inserted culture dish with the epithelial layer facing up, placed on the bottom of the inserted culture dish, and placed in a 5% CO 2 incubator at 37°C After being firmly pasted under certain conditions, it is made into a carrier bracket for use;
3)组织工程人角膜上皮的构建3) Construction of tissue engineered human corneal epithelium
最后,在贴有去上皮层消化羊膜载体支架的插入式培养皿中,轻轻加入上述准备好的人角膜上皮细胞悬液0.1~0.2毫升,使细胞悬液均匀分散于插入式培养皿中,6孔培养板孔中不加培养液,置5%CO2培养箱中37℃培养20~24小时待细胞完全贴附到载体支架上后,吸去插入式培养皿内的旧培养液,将插入式培养皿轻轻放入已加入0.8毫升含10%小牛血清的DMEM培养液的6孔培养板中,建立气-液界面培养环境,在5%CO2培养箱中37℃培养启动组织工程人角膜上皮的体外重建,每隔12小时轻轻摇动6孔培养板,每隔24~36小时换液一次,待人角膜上皮细胞在载体支架上长成6~8层后即为重建的组织工程人角膜上皮。Finally, gently add 0.1 to 0.2 ml of the human corneal epithelial cell suspension prepared above to the insert culture dish with the carrier bracket of de-epithelialized amniotic membrane, so that the cell suspension is evenly dispersed in the insert culture dish, No culture solution was added to the wells of the 6-well culture plate, and cultured in a 5% CO2 incubator at 37°C for 20-24 hours. Gently place the insert culture dish into a 6-well culture plate that has been added with 0.8 ml of DMEM culture solution containing 10% calf serum to establish an air-liquid interface culture environment, and culture the starter tissue at 37°C in a 5% CO2 incubator For in vitro reconstruction of engineered human corneal epithelium, gently shake the 6-well culture plate every 12 hours, and change the medium every 24 to 36 hours. After the human corneal epithelial cells grow into 6 to 8 layers on the carrier scaffold, it will be the reconstructed tissue Engineered human corneal epithelium.
本发明利用无致瘤性、非转染的人角膜上皮细胞,能通过连续传代为组织工程人角膜上皮的规模化体外重建提供出足量的种子细胞;利用商品化冻干羊膜所制备的去上皮层消化羊膜,可满足组织工程人角膜上皮批量重建所需要的大量载体支架材料;而且可直接应用于批量生产和临床角膜移植;且其生产和临床治疗的成本低。The invention utilizes non-tumorigenic, non-transfected human corneal epithelial cells to provide sufficient seed cells for large-scale in vitro reconstruction of tissue-engineered human corneal epithelial cells through continuous passage; The epithelial layer digests the amniotic membrane, which can meet the large amount of carrier and scaffold materials required for mass reconstruction of tissue-engineered human corneal epithelium; and can be directly applied to mass production and clinical corneal transplantation; and its production and clinical treatment costs are low.
具体实施方式 Detailed ways
下面结合具体实施例对本发明的方法进行详细的描述Below in conjunction with specific embodiment the method of the present invention is described in detail
一、人角膜上皮细胞系的建立1. Establishment of human corneal epithelial cell line
1、角膜片贴板培养的启动:从眼库中取出2个完整的人角膜,放入100毫升玻璃烧杯中,加入10~30毫升浓度为0.9%的生理盐水,清洗5~9分钟;吸出生理盐水后,加入10~30毫升的浓度为20%~70%的庆大霉素,浸泡15~35分钟,于超净工作台中进行消毒,以下操作均在超净工作台中进行,所有用品均是无菌的;用眼科镊从庆大霉素液中取出角膜,将角膜的凹面朝上平放于玻璃培养皿中,玻璃培养皿中加入0.2~0.5%胰蛋白酶5~10毫升消化1~2分钟;去除胰蛋白酶液,用眼科镊撕下带前弹力层的角膜上皮,用眼科剪沿角膜中心点把带有前弹力层的角膜上皮平均剪成8片,用眼科镊将角膜上皮面朝下平贴入24孔培养板的孔底,向贴入角膜上皮片的培养孔中加入0.1~0.3毫升培养液,培养液的体积量即保证角膜上皮片能够很好的贴附在培养孔底,又保证组织片不会干燥。将培养板放入5%二氧化碳培养箱中,37℃进行培养;1. Start of corneal patch culture: Take out 2 complete human corneas from the eye bank, put them into a 100ml glass beaker, add 10-30ml of 0.9% normal saline, wash for 5-9 minutes; suck out After the normal saline, add 10-30 ml of gentamicin with a concentration of 20%-70%, soak for 15-35 minutes, and then disinfect in the ultra-clean workbench. The following operations are all carried out in the ultra-clean workbench. It is sterile; use ophthalmic tweezers to take out the cornea from the gentamicin solution, put the concave surface of the cornea upwards in a glass petri dish, add 0.2-0.5% trypsin in 5-10 ml to digest 1~ 2 minutes; remove the trypsin solution, tear off the corneal epithelium with Bowman's membrane with ophthalmic forceps, cut the corneal epithelium with Bowman's membrane into 8 pieces on average along the center of the cornea with ophthalmic scissors, and cut the corneal epithelium with ophthalmic forceps Put it flat into the bottom of the 24-well culture plate, and add 0.1-0.3 ml of culture solution to the culture well where the corneal epithelium is attached. The volume of the culture solution is enough to ensure that the corneal epithelium can be well attached to the bottom of the culture hole , and ensure that the tissue sheet will not dry out. Put the culture plate into a 5% carbon dioxide incubator and culture at 37°C;
2、组织块法进行人角膜上皮细胞培养:角膜上皮片贴板培养12-24小时后,向每个培养孔中补加角膜上皮细胞专用培养液至1毫升,于5%二氧化碳培养箱中、37℃培养;每间隔3~5天,更换人角膜上皮细胞专用培养液一次。2. Human corneal epithelial cell culture by tissue block method: after 12-24 hours of corneal epithelial patch culture, add corneal epithelial cell special culture medium to each culture well to 1 ml, in a 5% carbon dioxide incubator, Culture at 37°C; every 3 to 5 days, replace the special culture medium for human corneal epithelial cells once.
3、人角膜上皮细胞专用培养液的配制:取常规配制的DMEM/F12培养液3.0毫升,然后依次加入硫酸软骨素1~4毫克、羧甲基壳寡糖0.2~0.6毫克和IV型胶原0.08~0.4毫克,完全溶解后用0.22微米的微孔滤膜过滤除菌,加入0.8毫升胎牛血清,又添加了0.01‰~0.02‰的人表皮细胞生长因子和0.01‰~0.02‰的碱性成纤维细胞生长因子,补加常规配制的DMEM/F12培养液至4.0毫升,即为本发明的人角膜上皮细胞专用培养液。3. Preparation of special culture medium for human corneal epithelial cells: Take 3.0 ml of conventionally prepared DMEM/F12 culture medium, and then add 1-4 mg of chondroitin sulfate, 0.2-0.6 mg of carboxymethyl chitosan oligosaccharide and 0.08 mg of type IV collagen ~0.4 mg, after completely dissolved, filter and sterilize with a 0.22 micron microporous membrane, add 0.8 ml of fetal bovine serum, add 0.01‰~0.02‰ of human epidermal growth factor and 0.01‰~0.02‰ of alkaline composition Fibroblast growth factor, supplemented with conventionally prepared DMEM/F12 culture solution to 4.0 milliliters, is the special culture solution for human corneal epithelial cells of the present invention.
4、人角膜上皮细胞的继代培养:待人角膜上皮细胞长成单层后,吸出培养孔中的培养液,向每个培养孔中加入0.5毫升浓度为0.25%的胰蛋白酶溶液,静置消化1~2分钟;吸去胰蛋白酶溶液,每培养孔中加入1毫升的上述专用培养液,用滴管吹打培养孔底3~5分钟制成人角膜上皮细胞悬液;从每培养孔中分别取出0.5毫升角膜上皮细胞悬液,分别加入到新的培养孔中,每个培养孔补加上述专用培养液0.5毫升,使之最终体积至1毫升;待人角膜上皮细胞再次长成单层后,仍以上述的相同方法进行继代培养。4. Subculture of human corneal epithelial cells: After the human corneal epithelial cells grow into a single layer, suck out the culture medium in the culture wells, add 0.5 ml of trypsin solution with a concentration of 0.25% to each culture well, and let stand to digest 1 to 2 minutes; suck the trypsin solution, add 1 ml of the above-mentioned special culture solution to each culture well, and blow the bottom of the culture well with a dropper for 3 to 5 minutes to make a suspension of human corneal epithelial cells; remove from each culture well Add 0.5 ml of corneal epithelial cell suspension to new culture wells, and add 0.5 ml of the above-mentioned special culture solution to each culture well to make the final volume reach 1 ml; after human corneal epithelial cells grow into a monolayer again, the Subculture was carried out in the same manner as above.
实施例1Example 1
从眼库中取出2个完整的人角膜,放入100毫升玻璃烧杯中,加入10毫升浓度为0.9%的生理盐水,清洗5分钟;吸出生理盐水后,加入10毫升的浓度为20%的庆大霉素,浸泡35分钟,于超净工作台中进行消毒;以下操作均在超净工作台中进行,所有用品均是无菌的;用眼科镊从庆大霉素液中取出角膜,将角膜的凹面朝上平放于玻璃培养皿中,培养皿中加入0.2%胰蛋白酶5毫升消化2分钟后,去除胰蛋白酶液,用眼科镊撕下带有前弹力层的角膜上皮,用眼科剪沿角膜中心点把带有前弹力层的角膜上皮平均剪成8片,用眼科镊将角膜上皮面朝下平贴入24孔培养板的孔底,每个培养孔补加含有20%胎牛血清的DMEM/F12培养液0.1毫升;将培养板放入5%二氧化碳培养箱中,37℃进行培养。取常规配制的DMEM/F12培养液3.0毫升,完全溶解后用0.22微米的微孔滤膜过滤除菌,加入0.8毫升胎牛血清,又加入0.01‰~0.02‰的人表皮细胞生长因子和0.01‰~0.02‰的碱性成纤维细胞生长因子,补加常规配制的DMEM/F12培养液至4.0毫升,即为人角膜上皮细胞专用培养液。贴板培养12小时后,向每个培养孔中补加上述专用培养液至1毫升,于5%二氧化碳培养箱中、37℃培养;每间隔3天,更换人角膜上皮细胞专用培养液一次。待人角膜上皮细胞长成单层后,吸出培养孔中的培养液,向每个培养孔中加入0.5毫升浓度为0.25%的胰蛋白酶溶液,静置消化1分钟;吸去胰蛋白酶溶液,每培养孔中加入1毫升的上述专用培养液,用滴管吹打培养孔底3分钟制成人角膜上皮细胞悬液;从每个培养孔中分别取出0.5毫升角膜上皮细胞悬液,分别加入到新的培养孔中,每培养孔补加上述专用培养液0.5毫升,使之最终体积至1毫升;待人角膜上皮细胞再次长成单层后,仍以上述的相同方法进行继代培养。Take 2 complete human corneas from the eye bank, put them into a 100ml glass beaker, add 10ml of 0.9% normal saline, wash for 5 minutes; after sucking out the normal saline, add 10ml of 20% Qing Damycin, soaked for 35 minutes, and disinfected in the ultra-clean workbench; the following operations were carried out in the ultra-clean workbench, and all supplies were sterile; the cornea was taken out from the gentamicin solution with ophthalmic forceps, and the cornea Put the concave side up in a glass culture dish, add 5ml of 0.2% trypsin to the culture dish to digest for 2 minutes, remove the trypsin solution, use ophthalmic forceps to tear off the corneal epithelium with Descemet's layer, and use ophthalmic scissors to cut off the corneal epithelium Cut the corneal epithelium with Bowman's membrane into 8 pieces on average at the center point, put the corneal epithelium face down into the bottom of the 24-well culture plate with ophthalmic forceps, add DMEM containing 20% fetal bovine serum to each culture well /F12 culture solution 0.1 ml; put the culture plate into a 5% carbon dioxide incubator, and cultivate at 37°C. Take 3.0 ml of conventionally prepared DMEM/F12 culture solution, completely dissolve it and filter it with a 0.22-micron microporous membrane to sterilize it, add 0.8 ml of fetal bovine serum, add 0.01‰~0.02‰ of human epidermal growth factor and 0.01‰ ~0.02‰ basic fibroblast growth factor, supplemented with conventionally prepared DMEM/F12 culture medium to 4.0 ml, which is the special culture medium for human corneal epithelial cells. After 12 hours of plate-based culture, add the above-mentioned special culture medium to each culture well to 1 ml, and culture in a 5% carbon dioxide incubator at 37°C; every 3 days, replace the special culture medium for human corneal epithelial cells once. After the human corneal epithelial cells grow into a single layer, suck out the culture solution in the culture wells, add 0.5 ml of trypsin solution with a concentration of 0.25% to each culture well, and let it stand for digestion for 1 minute; Add 1 ml of the above-mentioned special culture solution into the well, blow the bottom of the culture well with a dropper for 3 minutes to make a suspension of human corneal epithelial cells; take 0.5 ml of the suspension of corneal epithelial cells from each culture well, and add them to the new In each well, add 0.5 ml of the above-mentioned special culture medium to make the final volume to 1 ml; after the human corneal epithelial cells grow into a single layer again, carry out subculture in the same method as above.
二、组织工程人角膜上皮的重建2. Reconstruction of tissue-engineered human corneal epithelium
1、角膜上皮重建专用培养液的配制:取常规配制的DMEM/F12培养液80毫升,加入IV型胶原蛋白4~8毫克,完全溶解后用0.22微米的微孔滤膜过滤除菌,加入10毫升小牛血清,补加常规配制的DMEM/F12培养液至100毫升,即为本发明的角膜上皮重建专用培养液。1. Preparation of special culture medium for corneal epithelial reconstruction: take 80 ml of conventionally prepared DMEM/F12 culture medium, add 4-8 mg of type IV collagen, and filter it through a 0.22-micron microporous membrane to sterilize after completely dissolving, add 10 1 milliliter of calf serum is supplemented with conventionally prepared DMEM/F12 culture solution to 100 milliliters, which is the special culture solution for corneal epithelial reconstruction of the present invention.
2、人角膜上皮种子细胞的制备:取人角膜上皮细胞,悬浮于20%小牛血清-DMEM/F12培养液中,接种至底面积为75平方厘米的培养瓶中,置37℃进行扩增培养,细胞增殖72~80小时至对数生长期后,用玻璃滴管吸出培养液,加入0.25%胰蛋白酶溶液消化1~2分钟,加入此前吸出的培养液终止消化,1000~1500转/分离心10~15分钟,细胞沉淀用3毫升上述专用培养液悬浮均匀制成人角膜上皮种子细胞悬液,利用Casy细胞计数仪或血球计数板进行细胞计数后,用角膜上皮重建专用培养液调整种子细胞浓度至8×106~3×107个细胞/毫升。2. Preparation of human corneal epithelial seed cells: Take human corneal epithelial cells, suspend them in 20% calf serum-DMEM/F12 culture medium, inoculate them into a culture flask with a bottom area of 75 cm2, and place them at 37°C for amplification Culture, after 72-80 hours of cell proliferation to the logarithmic growth phase, suck out the culture solution with a glass dropper, add 0.25% trypsin solution to digest for 1-2 minutes, add the previously sucked culture solution to stop digestion, 1000-1500 rpm/separation Heart for 10-15 minutes, suspend the cell pellet with 3 ml of the above-mentioned special culture medium to make a suspension of human corneal epithelial seed cells, use a Casy cell counter or a hemocytometer to count the cells, and adjust the seed cells with the special culture medium for corneal epithelial reconstruction The concentration is 8×10 6 ~3×10 7 cells/ml.
3、去上皮层消化羊膜载体支架的制备:利用0.25%胰蛋白酶-0.1%EDTA溶液(1∶1)对冻干羊膜的上皮面进行倒置消化15~30分钟,以得到完全去除上皮层的羊膜,用D-hanks溶液漂洗2次后,用打孔器将去上皮层消化羊膜打成直径2.5厘米的去上皮层消化羊膜圆片。3. Preparation of amniotic membrane carrier scaffold with de-epithelial layer digestion: use 0.25% trypsin-0.1% EDTA solution (1:1) to carry out inverted digestion of the epithelial surface of the freeze-dried amniotic membrane for 15-30 minutes to obtain the amniotic membrane with the epithelial layer completely removed , after rinsing twice with D-hanks solution, punch the epithelialized digested amniotic membrane into a 2.5 cm diameter disc of the epithelialized digested amniotic membrane with a puncher.
4、组织工程人角膜上皮的体外重建:去上皮层消化羊膜圆片按照上皮面朝上的方向平铺于6孔培养板插入式培养皿的底部,放置于37℃培养箱中干贴处理20~24小时后制成去上皮层消化羊膜载体支架。在载体支架的插入式培养皿中,轻轻加入0.1~0.2毫升上述准备好的种子细胞悬液,轻轻吹打使细胞悬液均匀分散于插入式培养皿中,置5%CO2培养箱中37℃培养20~26小时待细胞完全贴附到载体支架上后,吸去插入式培养皿内的旧培养液,将插入式培养皿轻轻放入已加入0.8毫升10%小牛血清-DMEM/F12培养液的6孔培养板中,在5%CO2培养箱中37℃进行组织工程人角膜上皮的体外重建,每隔12小时轻轻摇动6孔培养板,每隔24~36小时换液一次,待人角膜上皮细胞在载体支架上长成6~8层后即为重建的组织工程人角膜上皮。4. In vitro reconstruction of tissue-engineered human corneal epithelium: Digested amniotic membrane discs with epithelial layer removed were spread on the bottom of a 6-well culture plate with the epithelial side facing up, and placed in a 37°C incubator for 20 days. ~24 hours later, the de-epithelialized digested amniotic membrane carrier scaffold was made. Gently add 0.1-0.2 ml of the seed cell suspension prepared above to the insert culture dish of the carrier bracket, blow gently to disperse the cell suspension evenly in the insert culture dish, and place in a 5% CO2 incubator Incubate at 37°C for 20 to 26 hours. After the cells are completely attached to the carrier bracket, suck off the old culture medium in the insert culture dish, and gently put the insert culture dish into DMEM that has been added with 0.8 ml of 10% calf serum. In the 6-well culture plate of /F12 culture medium, the in vitro reconstruction of tissue-engineered human corneal epithelium was carried out in a 5% CO 2 incubator at 37°C, and the 6-well culture plate was gently shaken every 12 hours, and changed every 24-36 hours. After the human corneal epithelial cells grow into 6-8 layers on the carrier scaffold, the reconstructed tissue engineered human corneal epithelium is obtained.
实施例2Example 2
取人角膜上皮细胞,悬浮于20%小牛血清-DMEM/F12培养液中,接种至底面积为75平方厘米的培养瓶中,置37℃进行扩增培养80小时。取常规配制的DMEM/F12培养液80毫升,加入IV型胶原蛋白8毫克,完全溶解后用0.22微米的微孔滤膜过滤除菌,加入10毫升小牛血清,补加常规配制的DMEM/F12培养液至100毫升,即为本发明的角膜上皮重建专用培养液。对扩增培养后的培养瓶,用玻璃滴管吸出培养液,加入0.25%胰蛋白酶溶液消化1.5分钟,加入此前吸出的旧培养液终止消化,1500转/分离心10分钟,获得细胞沉淀,用3毫升上述专用培养液悬浮均匀制成人角膜上皮细胞悬液;利用Casy细胞计数仪或血球计数板进行细胞计数,用上述专用培养液调整细胞浓度至1.5×107个细胞/毫升。Human corneal epithelial cells were taken, suspended in 20% calf serum-DMEM/F12 culture medium, inoculated into a culture flask with a bottom area of 75 square centimeters, and cultured at 37°C for 80 hours. Take 80 ml of conventionally prepared DMEM/F12 culture solution, add 8 mg of type IV collagen, filter and sterilize with a 0.22 micron microporous membrane after completely dissolving, add 10 ml of calf serum, and add conventionally prepared DMEM/F12 The culture fluid to 100 milliliters is the special culture fluid for corneal epithelial reconstruction of the present invention. For the culture bottle after the expansion culture, use a glass dropper to suck out the culture solution, add 0.25% trypsin solution to digest for 1.5 minutes, add the old culture solution sucked out before to stop the digestion, centrifuge at 1500 rpm for 10 minutes, obtain the cell pellet, and use Suspend 3 ml of the above-mentioned special culture medium evenly to make a suspension of human corneal epithelial cells; use a Casy cell counter or a hemocytometer to count the cells, and use the above-mentioned special culture medium to adjust the cell concentration to 1.5×10 7 cells/ml.
利用0.25%胰蛋白酶-0.1%EDTA溶液(1∶1)对冻干羊膜的上皮面进行倒置消化20分钟,以得到完全去除上皮层的羊膜,用D-hanks溶液漂洗2次后,用打孔器将去上皮层消化羊膜打成直径2.5厘米的去上皮层消化羊膜圆片,按照上皮面朝上的方向平铺于6孔培养板插入式培养皿的底部,放置于37℃培养箱中干贴处理24小时后制成去上皮层消化羊膜载体支架。在载体支架的插入式培养皿中,轻轻加入0.15毫升上述准备好的种子细胞悬液,轻轻吹打使细胞悬液均匀分散于插入式培养皿中,置5%CO2培养箱中37℃培养24小时待细胞完全贴附到载体支架上后,吸去插入式培养皿孔内的旧培养液,将插入式培养皿轻轻放入已加入0.8毫升10%小牛血清-DMEM培养液的6孔培养板中,建立气-液界面培养环境,在5%CO2培养箱中37℃进行组织工程人角膜上皮的体外重建,每隔12小时轻轻摇动6孔培养板,每隔30小时换液一次,待人角膜上皮细胞在载体支架上长成6~8层后即为重建的组织工程人角膜上皮。Use 0.25% trypsin-0.1% EDTA solution (1:1) to digest the epithelial surface of the freeze-dried amnion upside down for 20 minutes to obtain the amniotic membrane that completely removes the epithelial layer, rinse twice with D-hanks solution, and punch Cut the epithelium-free digested amniotic membrane into 2.5cm-diameter discs of the epithelial-digested amniotic membrane, spread them on the bottom of a 6-well culture plate with the epithelial side facing up, and place them in a 37°C incubator to dry. After 24 hours of pasting treatment, the de-epithelialized digested amniotic membrane carrier scaffold was made. Gently add 0.15 ml of the seed cell suspension prepared above to the inserted culture dish of the carrier bracket, blow gently to disperse the cell suspension evenly in the inserted culture dish, and place in a 5% CO2 incubator at 37°C Cultivate for 24 hours until the cells are completely attached to the carrier bracket, suck off the old culture medium in the hole of the insert culture dish, and gently put the insert culture dish into the medium that has added 0.8 ml of 10% calf serum-DMEM culture medium. In a 6-well culture plate, establish an air-liquid interface culture environment, and perform in vitro reconstruction of tissue-engineered human corneal epithelium in a 5% CO 2 incubator at 37°C. Gently shake the 6-well culture plate every 12 hours, and every 30 hours The liquid is changed once, and the tissue-engineered human corneal epithelium is reconstructed after the human corneal epithelial cells grow into 6-8 layers on the carrier scaffold.
实施例3Example 3
取人角膜上皮单克隆细胞株细胞,悬浮于20%小牛血清-DMEM/F12培养液中,接种至底面积为75平方厘米的培养瓶中,置37℃进行扩增培养72小时。取常规配制的DMEM/F12培养液80毫升,加入IV型胶原蛋白6毫克,完全溶解后用0.22微米的微孔滤膜过滤除菌,加入10毫升小牛血清,补加常规配制的DMEM/F12培养液至100毫升,即为本发明的角膜上皮重建专用培养液。对扩增培养后的培养瓶,用玻璃滴管吸出培养液,加入0.25%胰蛋白酶溶液消化1分钟,加入此前吸出的旧培养液终止消化,1000转/分离心15分钟,获得细胞沉淀,用3毫升上述专用培养液悬浮均匀制成人角膜上皮细胞悬液;利用Casy细胞计数仪或血球计数板进行细胞计数,用上述专用培养液调整细胞浓度至3×107个细胞/毫升。Human corneal epithelial monoclonal cells were taken, suspended in 20% calf serum-DMEM/F12 culture medium, inoculated into a culture flask with a bottom area of 75 cm2, and placed at 37°C for expansion and culture for 72 hours. Take 80 ml of conventionally prepared DMEM/F12 culture solution, add 6 mg of type IV collagen, filter and sterilize with a 0.22 micron microporous membrane after completely dissolving, add 10 ml of calf serum, and add conventionally prepared DMEM/F12 The culture fluid to 100 milliliters is the special culture fluid for corneal epithelial reconstruction of the present invention. For the culture bottle after the amplification culture, use a glass dropper to suck out the culture solution, add 0.25% trypsin solution to digest for 1 minute, add the old culture solution sucked out before to stop the digestion, centrifuge at 1000 rpm for 15 minutes, obtain the cell pellet, and use Suspend 3 ml of the above-mentioned special culture medium evenly to make a suspension of human corneal epithelial cells; use a Casy cell counter or a hemocytometer to count the cells, and use the above-mentioned special culture medium to adjust the cell concentration to 3×10 7 cells/ml.
利用0.25%胰蛋白酶-0.1%EDTA溶液(1∶1)对冻干羊膜的上皮面进行倒置消化15分钟,以得到完全去除上皮层的羊膜,用D-hanks溶液漂洗2次后,用打孔器将去上皮层消化羊膜打成直径2.5厘米的去上皮层消化羊膜圆片,按照上皮面朝上的方向平铺于6孔培养板插入式培养皿的底部,放置于37℃培养箱中干贴处理20小时后制成去上皮层消化羊膜载体支架。在载体支架的插入式培养皿中,轻轻加入0.1毫升上述准备好的种子细胞悬液,轻轻吹打使细胞悬液均匀分散于插入式培养皿中,置5%CO2培养箱中37℃培养26小时待细胞完全贴附到载体支架上后,吸去插入式培养皿内的旧培养液,将插入式培养皿轻轻放入已加入0.8毫升10%小牛血清-DMEM/F12培养液的6孔培养板中,在5%CO2培养箱中37℃进行组织工程人角膜上皮的体外重建,每隔12小时轻轻摇动6孔培养板,每隔24小时换液一次,待人角膜上皮细胞在载体支架上长成6~8层后即为重建的组织工程人角膜上皮。Use 0.25% trypsin-0.1% EDTA solution (1:1) to digest the epithelial surface of the freeze-dried amniotic membrane upside down for 15 minutes to obtain the amniotic membrane that completely removes the epithelial layer, rinse twice with D-hanks solution, and punch Cut the epithelium-free digested amniotic membrane into 2.5cm-diameter discs of the epithelial-digested amniotic membrane, spread them on the bottom of a 6-well culture plate with the epithelial side facing up, and place them in a 37°C incubator to dry. After 20 hours of pasting treatment, the de-epithelialized digested amniotic membrane carrier scaffold was made. Gently add 0.1 ml of the seed cell suspension prepared above to the inserted culture dish of the carrier bracket, gently pipette to disperse the cell suspension evenly in the inserted culture dish, and place in a 5% CO2 incubator at 37°C Cultivate for 26 hours until the cells are completely attached to the carrier bracket, suck off the old culture medium in the insert culture dish, and gently put the insert culture dish into the DMEM/F12 culture medium with 0.8 ml of 10% calf serum-DMEM/F12 In vitro reconstruction of tissue-engineered human corneal epithelium was carried out in a 5% CO2 incubator at 37°C in a 6-well culture plate. The 6-well culture plate was gently shaken every 12 hours, and the medium was changed every 24 hours. The reconstructed tissue engineered human corneal epithelium is obtained after the cells grow into 6-8 layers on the carrier scaffold.
实施例4Example 4
取人角膜上皮单克隆细胞株细胞,悬浮于20%小牛血清-DMEM/F12培养液中,接种至底面积为75平方厘米的培养瓶中,置37℃进行扩增培养75小时。取常规配制的DMEM/F12培养液80毫升,加入IV型胶原蛋白4毫克,完全溶解后用0.22微米的微孔滤膜过滤除菌,加入10毫升小牛血清,补加常规配制的DMEM/F12培养液至100毫升,即为本发明的角膜上皮重建专用培养液。对扩增培养后的培养瓶,用玻璃滴管吸出培养液,加入0.25%胰蛋白酶溶液消化2分钟,加入此前吸出的旧培养液终止消化,1200转/分离心10分钟,获得细胞沉淀,用3毫升上述专用培养液悬浮均匀制成人角膜上皮细胞悬液;利用Casy细胞计数仪或血球计数板进行细胞计数,用上述专用培养液调整细胞浓度至8×106个细胞/毫升。Take human corneal epithelial monoclonal cell line cells, suspend them in 20% calf serum-DMEM/F12 culture medium, inoculate them into a culture flask with a bottom area of 75 square centimeters, and place them at 37°C for expansion and culture for 75 hours. Take 80 ml of conventionally prepared DMEM/F12 culture solution, add 4 mg of type IV collagen, filter and sterilize with a 0.22 micron microporous membrane after completely dissolving, add 10 ml of calf serum, and add conventionally prepared DMEM/F12 The culture fluid to 100 milliliters is the special culture fluid for corneal epithelial reconstruction of the present invention. For the culture bottle after the expansion culture, use a glass dropper to suck out the culture solution, add 0.25% trypsin solution to digest for 2 minutes, add the old culture solution sucked out before to stop the digestion, and centrifuge at 1200 rpm for 10 minutes to obtain the cell pellet. Suspend 3 ml of the above-mentioned special culture medium evenly to make a suspension of human corneal epithelial cells; use a Casy cell counter or a hemocytometer to count the cells, and use the above-mentioned special culture medium to adjust the cell concentration to 8×10 6 cells/ml.
利用0.25%胰蛋白酶-0.1%EDTA溶液(1∶1)溶液对冻干羊膜的上皮面进行倒置消化30分钟,以得到完全去除上皮层的羊膜,用D-hanks溶液漂洗2次后,用打孔器将去上皮层消化羊膜打成直径2.5厘米的去上皮层消化羊膜圆片,按照上皮面朝上的方向平铺于6孔培养板插入式培养皿的底部,放置于37℃培养箱中干贴处理22小时后制成去上皮层消化羊膜载体支架。在载体支架的插入式培养皿中,轻轻加入0.2毫升上述准备好的种子细胞悬液,轻轻吹打使细胞悬液均匀分散于插入式培养皿中,置5%CO2培养箱中37℃培养20小时待细胞完全贴附到载体支架上后,吸去插入式培养皿内的旧培养液,将插入式培养皿轻轻放入已加入0.8毫升10%小牛血清-DMEM/F12培养液的6孔培养板中,在5%CO2培养箱中37℃进行组织工程人角膜上皮的体外重建,每隔12小时轻轻摇动6孔培养板,每隔36小时换液一次,待人角膜上皮细胞在载体支架上长成6~8层后即为重建的组织工程人角膜上皮。Use 0.25% trypsin-0.1% EDTA solution (1:1) to digest the epithelial surface of the freeze-dried amnion upside down for 30 minutes to obtain the amnion with the epithelial layer completely removed, rinse twice with D-hanks solution, and then rinse Cut the epithelium-free digested amniotic membrane into 2.5cm-diameter discs of the epithelial-digested amniotic membrane with a puncher, spread them on the bottom of a 6-well culture plate insert culture dish with the epithelial side facing upwards, and place them in a 37°C incubator After 22 hours of dry paste treatment, the de-epithelialized digested amniotic membrane carrier scaffold was made. Gently add 0.2 ml of the seed cell suspension prepared above to the inserted culture dish of the carrier bracket, blow gently to disperse the cell suspension evenly in the inserted culture dish, and place in a 5% CO2 incubator at 37°C Cultivate for 20 hours until the cells are completely attached to the carrier bracket, suck off the old culture medium in the insert culture dish, and gently put the insert culture dish into 0.8 ml of 10% calf serum-DMEM/F12 culture medium In vitro reconstruction of tissue-engineered human corneal epithelium in a 5% CO2 incubator at 37°C, gently shake the 6-well culture plate every 12 hours, change the medium every 36 hours, and treat the human corneal epithelium The reconstructed tissue engineered human corneal epithelium is obtained after the cells grow into 6-8 layers on the carrier scaffold.
本发明的方法所重建出的组织工程人角膜上皮在形态结构和透明度上与正常角膜上皮相似并具有正常角膜上皮的功能。为了更好的验证本发明方法所获得的组织工程人角膜上皮具有生物学上的功能,将本发明所重建的组织工程人角膜上皮移植到去除角膜缘干细胞及刮除角膜上皮层的新西兰兔眼中,实验结果表明,移植的组织工程人角膜上皮可使兔眼角膜恢复透明长达180天以上,并且移植的上皮能够防御细菌的侵染。三次重复的结果都表明应用本发明方法构建的组织工程人角膜上皮具有替代自生角膜的前景。The tissue engineered human corneal epithelium rebuilt by the method of the invention is similar to normal corneal epithelium in terms of morphology, structure and transparency, and has the function of normal corneal epithelium. In order to better verify that the tissue-engineered human corneal epithelium obtained by the method of the present invention has biological functions, the reconstructed tissue-engineered human corneal epithelium of the present invention was transplanted into New Zealand rabbit eyes from which limbal stem cells were removed and the corneal epithelial layer was scraped. , the experimental results show that the transplanted tissue engineered human corneal epithelium can restore the transparency of the rabbit cornea for more than 180 days, and the transplanted epithelium can defend against bacterial infection. The results of three repetitions all show that the tissue engineered human corneal epithelium constructed by the method of the present invention has the prospect of replacing the native cornea.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110039099 CN102166375B (en) | 2011-02-16 | 2011-02-16 | Reconstruction method of tissue engineering human corneal epithelium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110039099 CN102166375B (en) | 2011-02-16 | 2011-02-16 | Reconstruction method of tissue engineering human corneal epithelium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102166375A CN102166375A (en) | 2011-08-31 |
| CN102166375B true CN102166375B (en) | 2013-04-10 |
Family
ID=44487814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110039099 Expired - Fee Related CN102166375B (en) | 2011-02-16 | 2011-02-16 | Reconstruction method of tissue engineering human corneal epithelium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102166375B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2481087C1 (en) * | 2012-02-15 | 2013-05-10 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения и социального развития Российской Федерации | Method of treating inflammatory and trophic injuries of cornea |
| CN102787095A (en) * | 2012-07-06 | 2012-11-21 | 广州医学院第一附属医院 | Method for cultivating rat primary airway epithelial cells |
| CN104877958B (en) * | 2014-02-28 | 2018-01-02 | 上海尚瑞生物医药科技有限公司 | A kind of cell line for keeping corneal epithelium shape cellular layer transparency |
| CN106591216B (en) * | 2016-12-12 | 2021-07-27 | 深圳市眼科医院 | Human normal corneal epithelial cell and application thereof |
| CN106955372B (en) * | 2017-04-12 | 2020-08-14 | 山东省眼科研究所 | Method for constructing tissue engineering corneal endothelium |
| CN107326003B (en) * | 2017-06-18 | 2020-09-25 | 广东博溪生物科技有限公司 | 3D model constructed in vitro by using serum-free culture solution and construction method thereof |
| CN107164309B (en) * | 2017-06-18 | 2023-06-16 | 广东博溪生物科技有限公司 | 3D model constructed outside serum-containing culture liquid and construction method thereof |
| CN107129966B (en) * | 2017-06-18 | 2023-03-03 | 广东博溪生物科技有限公司 | Serum-containing corneal epithelial cell culture solution |
| CN108277204A (en) * | 2018-01-10 | 2018-07-13 | 山东麦德克斯生物科技有限公司 | A kind of method that bioengineering cultivates eye Full-thickness corneal |
| CN109517051B (en) * | 2018-12-03 | 2020-10-16 | 拉菲尔(深圳)投资咨询有限公司 | Method for inducing human epidermal stem cells into corneal epithelial cells |
| CN112941014A (en) * | 2021-02-22 | 2021-06-11 | 深圳艾尼尔角膜工程有限公司 | Method for improving adhesion of tissue engineering anterior lamellar corneal epithelial cells |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1426289A (en) * | 2000-04-27 | 2003-06-25 | 雷·瑞芳·蔡 | Expansion methods for epithelial stem cells |
| CN1749393A (en) * | 2005-07-27 | 2006-03-22 | 中国海洋大学 | A kind of construction method of human corneal endothelial cell line |
| CN101508971A (en) * | 2009-03-23 | 2009-08-19 | 中国海洋大学 | Tissue engineering reconstruction method for human corneal endothelium |
-
2011
- 2011-02-16 CN CN 201110039099 patent/CN102166375B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1426289A (en) * | 2000-04-27 | 2003-06-25 | 雷·瑞芳·蔡 | Expansion methods for epithelial stem cells |
| CN1749393A (en) * | 2005-07-27 | 2006-03-22 | 中国海洋大学 | A kind of construction method of human corneal endothelial cell line |
| CN101508971A (en) * | 2009-03-23 | 2009-08-19 | 中国海洋大学 | Tissue engineering reconstruction method for human corneal endothelium |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102166375A (en) | 2011-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102166375B (en) | Reconstruction method of tissue engineering human corneal epithelium | |
| CN101433478B (en) | Whole layer biological cornea as well as construction method and use thereof | |
| KR101293364B1 (en) | Method for reconstructing tissue engineered human corneal endothelium | |
| CN101757690B (en) | Method for preparing tissue engineering cornea | |
| JP5946046B2 (en) | Human corneal endothelial cell sheet | |
| CN101306207B (en) | Tissue engineered cornea epithelial transplantation membrane and preparation method and use thereof | |
| CN103656742B (en) | Preparation method of functionalized retinal pigment epithelial cell graft | |
| CN106591235A (en) | Method for promoting function and characteristic of corneal endothelial cells | |
| CN104645416B (en) | A kind of vitro construction method of organizational project people corneal stroma | |
| CN102166374B (en) | Method for preparing amniotic compound corneal limbus stem cell membrane | |
| CN101597592B (en) | Human corneal endothelial cell culture solution as well as preparation method and application thereof | |
| CN109517784B (en) | Similar corneal epithelial cell, tissue engineered corneal epithelium, preparation and application | |
| CN1563366A (en) | Preparation method and application of epidermal stem cell constructed tissue engineering corneal epithelial implant | |
| CN101843923B (en) | Method for preparing carrier bracket of tissue engineering artificial corneal endothelium by using fresh amniotic membrane | |
| CN102168064B (en) | Method for constructing human corneal epithelial cell system | |
| CN119799635A (en) | A method for culturing porcine limbal epithelial stem cells and its application | |
| CN111110921A (en) | A method for in vitro construction of lamellar cornea after tissue engineering | |
| CN1296479C (en) | Constructing method for human corneal endothelium cell system | |
| CN109321527A (en) | In vitro culture method for the stability of limbal stem cells | |
| CN109464705B (en) | A kind of RPE cell sheet and its application and preparation method | |
| CN108578778A (en) | A kind of cell for Ocular surface damage reparation plants piece and preparation method thereof | |
| CN102703375B (en) | A kind of construction process of people's keratocyte system | |
| US20250367347A1 (en) | Fibrin patch containing corneal epithelial cells and the method of manufacturing thereof | |
| CN107034171B (en) | A kind of cell culture processes using plant epidermis as tissue engineering bracket material | |
| CN115006593A (en) | In vitro construction of mechanically enhanced tissue-engineered corneal endothelium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130410 Termination date: 20220216 |